Viventia Bio Overview

  • Founded
  • 1995
Founded
  • Status
  • Acquired/​Merged
  • Latest Deal Type
  • M&A
  • Financing Rounds
  • 4

Viventia Bio General Information

Description

Producer of biopharmaceuticals. The company is engaged in the identification, development, production and marketing of biopharmaceuticals specializing in human monoclonal antibody therapies for the treatment of cancer.

Contact Information

Formerly Known As
Novopharm Biotech
Ownership Status
Acquired/Merged
Financing Status
Corporate Backed or Acquired
Primary Industry
Biotechnology
Other Industries
Pharmaceuticals
Acquirer
Primary Office
  • 147 Hamelin Street
  • Winnipeg, Manitoba R3T 3Z1
  • Canada
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Viventia Bio Valuation & Funding

Deal Type Date Amount Valuation/
EBITDA
Post-Val Status Debt

This information is available in the PitchBook Platform. To explore Viventia Bio‘s full profile, request access.

Request a free trial

Viventia Bio Comparisons

Description
Primary
Industry
HQ Location
Employees
Total Raised
Post Valuation
Last Financing Details
Producer of biopharmaceuticals. The company is engaged in the identification, development, production and marketing of b
Biotechnology
Winnipeg, Canada
00.00 0000-00-00
000000&0

000000

s nostrud exercitation ullamco laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolo
0000000000000
San Diego, CA
00 As of 0000
000.00
0000 0000-00-00
000000&0 000.00

00000000

co laboris nisi ut aliquip ex ea commodo consequat. Duis aute irure dolor in reprehenderit in volupt
0000000000000
Austin, TX
00 As of 0000
0000
0000 0000-00-00
00000000 0000
Add Comparison

PitchBook’s comparison feature gives you a side-by-side look at key metrics for similar companies. Personalize which data points you want to see and create visualizations instantly.

Request a free trial

Viventia Bio Competitors (50)

Company Name Financing Status Location Employees Total Raised Last Financing Date/Type Last Financing Amount
Pfenex Formerly VC-backed San Diego, CA 00 000.00 000000&0 000.00
00000000 Corporation Austin, TX 00 0000 00000000 0000
000000 Private Equity-Backed Mountain View, CA 00 000.00 0000000 0000 000.00
0000000 0000000000 Corporation Lexington, MA 0 0000 00000000 0000
00000 000 Formerly VC-backed Cambridge, MA 00 00000 00000000000 00000
You’re viewing 5 of 50 competitors. Get the full list »

Viventia Bio Executive Team (5)

Name Title Board Seat Contact Info
Gregory Adams Ph.D Chief Development Officer
Glen MacDonald Ph.D Chief Scientific Officer
Stephen Hurly Director, President & Chief Executive Officer
To view Viventia Bio’s complete executive team members history, request access »

Viventia Bio Board Members (1)

Name Representing Role Since
000000000 000000 00.0 Self Board Member 000 0000
To view Viventia Bio’s complete board members history, request access »

Viventia Bio Former Investors

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info

This information is available in the PitchBook Platform. To explore Viventia Bio‘s full profile, request access.

Request a free trial